Vanguard Capital Management’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.9M Hold
1,329,852
– – ﹤0.01% 3159
2026
Q2
$3.72M Buy
1,329,852
+14,870
+1% +$41.4K ﹤0.01% 3220
2026
Q1
$3.39M Buy
+1,314,982
New +$3.89M ﹤0.01% 3197

Other funds holding ANIX

Vanguard Capital Management's ANIX Position: Q3 2026 in Review

Vanguard Capital Management held its Anixa Biosciences (ANIX) position steady in Q3 2026 at 1,329,852 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3159.

Vanguard Capital Management first reported a position in ANIX in Q1 2026 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

  • Vanguard Capital Management held 1,329,852 shares of Anixa Biosciences worth $3.9M as of Q3 2026.
  • Vanguard Capital Management left its Anixa Biosciences share count unchanged in Q3 2026.
  • Anixa Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3159 holding.
  • Vanguard Capital Management first reported a position in Anixa Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.